Thenar Muscle Ultrasound in CTS Evaluation

December 9, 2024 updated by: Busra Sirin, Beylikduzu State Hospital

Is Ultrasound Measurement of Thenar Muscle Cross-Sectional Area Useful in the Evaluation of Carpal Tunnel Syndrome?: A Controlled Study

This study will include 20 patients aged 18-75 years who have been diagnosed with carpal tunnel syndrome (CTS) based on electrophysiological examinations performed within the last three months, as well as 20 healthy volunteers without a CTS diagnosis. Sociodemographic data such as age, gender, height, weight, and BMI will be recorded. Pinch grip strength will be evaluated using a Jamar pinch meter, and hand grip strength will be assessed using a Jamar dynamometer. Ultrasound will be used to measure the cross-sectional area and thickness of the thenar muscles as well as the cross-sectional area of the median nerve. Additionally, previous electrophysiological examination results will be recorded for the CTS patients.

Study Overview

Status

Not yet recruiting

Intervention / Treatment

Study Type

Observational

Enrollment (Estimated)

40

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

  • Name: Büşra Şirin Ahısha, MD
  • Phone Number: 02124443322
  • Email: bsrn080@gmail.com

Study Locations

    • Beylikdüzü
      • Istanbul, Beylikdüzü, Turkey, 34147
        • Beylikdüzü State Hospital

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Adult
  • Older Adult

Accepts Healthy Volunteers

N/A

Sampling Method

Probability Sample

Study Population

Carpal tunnel syndrome and healthy controls

Description

Inclusion Criteria:

  • Patients aged 18-75 years.
  • Diagnosed with carpal tunnel syndrome based on electrophysiological examination within the last 3 months.
  • Healthy volunteers without a diagnosis of carpal tunnel syndrome.
  • Volunteered to participate in the study.

Exclusion Criteria:

  • Refusal to participate in the study.
  • History of surgery due to carpal tunnel syndrome.
  • Presence of neuromuscular diseases.
  • Presence of advanced osteoarthritis.
  • Presence of psychiatric disorders.
  • Presence of cognitive impairments that may hinder study participation.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

Cohorts and Interventions

Group / Cohort
Intervention / Treatment
Carpal tunnel syndrome
Patients with carpal tunnel syndrome
No intervention
Control group
Healthy controls without carpal tunnel syndrome
No intervention

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Thenar Muscle Cross-Sectional Area (Ultrasound)
Time Frame: 0 day
Measurement of the cross-sectional area of the thenar muscles using ultrasound to determine muscle atrophy or changes associated with carpal tunnel syndrome.
0 day

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Thenar Muscle Thickness (Ultrasound)
Time Frame: 0 day
Assessment of the thickness of the thenar muscles using ultrasound to evaluate structural changes in patients with CTS.
0 day
Median Nerve Cross-Sectional Area (Ultrasound)
Time Frame: 0 day
Measurement of the median nerve's cross-sectional area using ultrasound, a parameter commonly associated with CTS diagnosis and severity.
0 day
Pinch Grip Strength
Time Frame: 0 day
Evaluated using the Jamar pinch meter, this outcome measures the functional strength of the thumb and index finger, which may be impaired in CTS.
0 day
Hand Grip Strength
Time Frame: 0 day
Assessed with a Jamar dynamometer, this outcome measures overall hand strength and provides insights into functional limitations caused by CTS.
0 day

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Büşra Şirin Ahısha, Beylikdüzü State Hospital

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Estimated)

December 10, 2024

Primary Completion (Estimated)

January 10, 2025

Study Completion (Estimated)

January 10, 2025

Study Registration Dates

First Submitted

December 9, 2024

First Submitted That Met QC Criteria

December 9, 2024

First Posted (Estimated)

December 12, 2024

Study Record Updates

Last Update Posted (Estimated)

December 12, 2024

Last Update Submitted That Met QC Criteria

December 9, 2024

Last Verified

December 1, 2024

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Carpal Tunnel Syndrome

Clinical Trials on No intervention

Subscribe